Development of explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in people with type 2 diabetes: A Delphi survey and consensus meeting
The list is specific for antidiabetic drugs (other than insulin) for people with type 2 diabetes. This explicit list could be implemented in a clinical decision support system for the automatic detection of PIPs and might help healthcare professionals involved in the management of people living with type 2 diabetes.
Authors
- Jean‐Baptiste Beuscart (ORCID: https://orcid.org/0000-0002-0734-8371)
- Paul Quindroit (ORCID: https://orcid.org/0000-0003-0387-2413)
- Sophie Gautier (ORCID: https://orcid.org/0000-0002-6557-8757)
- Jan Baran
- Erwin Gerard (ORCID: https://orcid.org/0000-0002-7712-4138)
- Madleen Lemaître (ORCID: https://orcid.org/0000-0002-3203-717X)
- Bertrand Décaudin (ORCID: https://orcid.org/0000-0001-8267-5594)
- Matthieu Calafiore (ORCID: https://orcid.org/0000-0002-4755-5172)
- N. Baclet (ORCID: https://orcid.org/0009-0000-4407-2178)
- Héloïse Henry (ORCID: https://orcid.org/0000-0001-9867-0456)
- Anne Vambergue
- Derya Bugday
Institutions
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Lille’s Cardiology Hospital (FR)
- Institut de Biologie de Lille (FR)
- European Genomic Institute for Diabetes (FR)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1371/journal.pone.0334836
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00